Garry Arthur Neil
CIK: 0001586785
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 25, 2026CLDX
Celldex Therapeutics, Inc.
Award(A)DirectNon-Qualified Stock Option (right to buy)
26K shares- - May 21, 2026AVTX
Avalo Therapeutics, Inc.
Award(A)Direct100.2K shares- - Feb 26, 2026AVTX
Avalo Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
286K shares- - Jun 5, 2025CLDX
Celldex Therapeutics, Inc.
Award(A)DirectNon-Qualified Stock Option (right to buy)
16.5K shares- - Mar 28, 2025AVTX
Avalo Therapeutics, Inc.
Exercise(M)Direct64.9K shares- - Mar 28, 2025AVTX
Avalo Therapeutics, Inc.
Tax Payment(F)Direct17.8K shares at avg. $8.46$150K - Jan 28, 2025AVTX
Avalo Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
411K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 |  CLDX Celldex Therapeutics, Inc. | Award(A) Non-Qualified Stock Option (right to buy) | 26,000 | - | - | Direct |
| May 21, 2026 |  AVTX Avalo Therapeutics, Inc. | Award(A) | 100,200 | - | $0 | Direct |
| Feb 26, 2026 | AVTX Avalo Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 286,000 | - | - | Direct |
| Jun 5, 2025 | CLDX Celldex Therapeutics, Inc. | Award(A) Non-Qualified Stock Option (right to buy) | 16,500 | - | - | Direct |
| Mar 28, 2025 | AVTX Avalo Therapeutics, Inc. | Exercise(M) | 64,867 | - | - | Direct |
| Mar 28, 2025 | AVTX Avalo Therapeutics, Inc. | Tax Payment(F) | 17,787 | $8.46 | $150,478 | Direct |
| Jan 28, 2025 | AVTX Avalo Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 411,000 | - | - | Direct |
1-7 of 7 transactions
About NEIL GARRY ARTHUR
NEIL GARRY ARTHUR (SEC CIK 0001586785) files insider reports with the SEC as Director of Celldex Therapeutics, Inc. (CLDX) and Chief Executive Officer of Avalo Therapeutics, Inc. (AVTX).
Signal8 holds 6 ownership filings by NEIL GARRY ARTHUR, all Form 4s, filed between Jan 30, 2025 and Jun 29, 2026. Those filings report 7 transactions, from Jan 28, 2025 to Jun 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on NEIL GARRY ARTHUR's filings is in HAMPTON, NJ.
Recent filings by NEIL GARRY ARTHUR
- Jun 25, 2026: Grant or award of CLDX derivative securities (Form 4, code A).
- May 21, 2026: Grant or award of AVTX shares (Form 4, code A).
- Feb 26, 2026: Grant or award of AVTX derivative securities (Form 4, code A).
- Jun 5, 2025: Grant or award of CLDX derivative securities (Form 4, code A).
- Mar 28, 2025: Option exercise of AVTX shares (Form 4, code M).
Other insiders filing for Celldex Therapeutics, Inc. (CLDX)
- Lawver Teri L, SVP & Chief Commercial Officer
- Jimenez Freddy A., SVP & GENERAL COUNSEL
- Young Diane C., SVP, CHIEF MEDICAL OFFICER
- Heath-Chiozzi Margo, SVP OF REGULATORY AFFAIRS
- Martin Samuel Bates, SVP AND CFO
- Cavanaugh Sarah, SVP OF CORP AFFAIRS & ADMIN.